Daniel Franzen1, Marisa Lim2, Daniel J Bratton2, Stefan P Kuster3, Malcolm Kohler2. 1. Department of Pulmonology, University Hospital and University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. daniel.franzen@usz.ch. 2. Department of Pulmonology, University Hospital and University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland. 3. Department of Infectious Diseases and Hospital Epidemiology, University Hospital and University of Zurich, Raemistrasse 100, 8091, Zurich, Switzerland.
Abstract
PURPOSE: In this retrospective study, we aimed to investigate the role of comorbidities using the Charlson comorbidity index (CCI) and time to first antibiotic dose (TFAD) in patients with pneumococcal community-acquired pneumonia (PCAP). METHODS: All consecutive ER admissions with PCAP who were hospitalized in the University Hospital, Zurich between 2006 and 2012 were included. The primary outcome was to determine possible determinants of all-cause in-hospital mortality (ACIHM). The second endpoint was to detect risk factors for adverse events (AEs) and determinants of length of stay (LOS). RESULTS: 108 subjects (mean age 57.6 years) were included. The median (IQR) CCI was 4 (1, 8). The median (IQR) TFAD was 210 (150, 280) min. ACIHM was 6.5 % (7/108), and median (IQR) LOS was 9 (6, 14) days. PCAP-related AEs were observed in 57 cases (52.8 %). In the multivariable analysis, neither CCI nor TFAD was associated with the outcome measures. Pneumonia severity index (PSI) was the only statistically significant predictor of ACIHM (HR 1.31/10 point increase, 95 % CI 1.12-1.53, p = 0.001) and AE rate (OR 1.31, 95 % CI 1.15-1.50, p < 0.001). CONCLUSIONS: In this study including comparatively young patients with rather mild disease severity, we found no strong evidence supporting that CCI or TFAD influenced short-term outcome measures of PCAP. Yet, pneumonia severity appears to be the most important factor for the outcome.
PURPOSE: In this retrospective study, we aimed to investigate the role of comorbidities using the Charlson comorbidity index (CCI) and time to first antibiotic dose (TFAD) in patients with pneumococcal community-acquired pneumonia (PCAP). METHODS: All consecutive ER admissions with PCAP who were hospitalized in the University Hospital, Zurich between 2006 and 2012 were included. The primary outcome was to determine possible determinants of all-cause in-hospital mortality (ACIHM). The second endpoint was to detect risk factors for adverse events (AEs) and determinants of length of stay (LOS). RESULTS: 108 subjects (mean age 57.6 years) were included. The median (IQR) CCI was 4 (1, 8). The median (IQR) TFAD was 210 (150, 280) min. ACIHM was 6.5 % (7/108), and median (IQR) LOS was 9 (6, 14) days. PCAP-related AEs were observed in 57 cases (52.8 %). In the multivariable analysis, neither CCI nor TFAD was associated with the outcome measures. Pneumonia severity index (PSI) was the only statistically significant predictor of ACIHM (HR 1.31/10 point increase, 95 % CI 1.12-1.53, p = 0.001) and AE rate (OR 1.31, 95 % CI 1.15-1.50, p < 0.001). CONCLUSIONS: In this study including comparatively young patients with rather mild disease severity, we found no strong evidence supporting that CCI or TFAD influenced short-term outcome measures of PCAP. Yet, pneumonia severity appears to be the most important factor for the outcome.
Entities:
Keywords:
Comorbidity; Pneumococcal community-acquired pneumonia; Pneumonia severity index; Short-term outcome; Time to first antibiotic dose
Authors: Lionel A Mandell; Richard G Wunderink; Antonio Anzueto; John G Bartlett; G Douglas Campbell; Nathan C Dean; Scott F Dowell; Thomas M File; Daniel M Musher; Michael S Niederman; Antonio Torres; Cynthia G Whitney Journal: Clin Infect Dis Date: 2007-03-01 Impact factor: 9.079
Authors: José Garnacho-Montero; Emilio García-Cabrera; Ana Diaz-Martín; Jose A Lepe-Jiménez; Patricia Iraurgi-Arcarazo; Rocio Jiménez-Alvarez; Jaume Revuelto-Rey; Javier Aznar-Martín Journal: Scand J Infect Dis Date: 2010-03
Authors: José Bordón; Paula Peyrani; Guy N Brock; Francesco Blasi; Jordi Rello; Thomas File; Julio Ramirez Journal: Chest Date: 2008-01-15 Impact factor: 9.410
Authors: Thomas Wesemann; Harald Nüllmann; Marc Andre Pflug; Hans Jürgen Heppner; Ludger Pientka; Ulrich Thiem Journal: BMC Infect Dis Date: 2015-01-08 Impact factor: 3.090